--- title: "Peptide Therapy Bloodwork: What to Test for Safety and Results" type: guide url: "https://www.test-well.com/guides/peptide-therapy-bloodwork" date_published: 2026-07-30 --- # Peptide Therapy Bloodwork: What to Test for Safety and Results *Whether you're on GLP-1s, BPC-157, or GH-releasing peptides, the only way to know a protocol is safe and working is bloodwork — before you start and on a schedule after.* > Peptides — from prescribed GLP-1s to research peptides like BPC-157 and GH secretagogues — act on the systems blood tests measure: metabolism, hormones, organ function, inflammation. You can't feel a peptide quietly stressing your liver or shifting your blood sugar; only bloodwork shows it. Standard cadence: a baseline before starting, a follow-up at 4–6 weeks, then quarterly. Bloodwork shows how your body responds; it does not test the vial's purity or contents. ## Recommended tests | Recommended | Type | Price | Why | | --- | --- | --- | --- | | [Peptide Therapy Monitoring Panel](https://www.test-well.com/tests/standardized-peptide-panel) | Panel (19 tests) | $259.99 | 53 biomarkers for BPC-157, GH-releasing peptides, and multi-peptide stacks — IGF-1, hormones, organ, metabolic | | [GLP-1 Monitoring & Weight Management](https://www.test-well.com/tests/glp1-monitoring-panel) | Panel (10 tests) | $169.99 | Purpose-built for semaglutide / tirzepatide (Ozempic, Wegovy, Mounjaro, Zepbound) safety + efficacy | | [IGF-1 (Insulin-like Growth Factor)](https://www.test-well.com/tests/igf-1-test) | Test | $37.99 | The single marker for GH-releasing peptides — order alone to track GH-axis response between full panels | All prices are cash-pay plus one $6 lab processing fee per order; physician authorization is included. ## Testing Your Body vs. Testing the Vial Search "peptide testing" and two completely different needs collide. Sorting them out first saves you from ordering the wrong thing: **Testing your body's response (this guide).** A blood test measures what a peptide is doing to your physiology — your IGF-1, hormones, blood sugar, liver and kidney function, inflammation. This is medical lab work, ordered online and drawn at Quest or Labcorp, and it's what tells you whether a protocol is safe for you and whether it's working. That's what TestWell provides. **Testing the vial's contents.** Verifying the identity, purity, or concentration of the peptide in a vial is analytical chemistry (mass spectrometry, HPLC) done by a substance-testing lab. A human medical lab cannot do it, and no blood test can tell you what was in the vial. If that's what you need, you're looking for a chemical assay service, not us. The rest of this guide is about the first case — using your own bloodwork to make peptide therapy safer and more measurable. ## Why Bloodwork Matters More With Peptides Than Almost Anything Else Peptides are signaling molecules — they tell your body to do something: release growth hormone, slow gastric emptying, modulate repair and inflammation. Because they act *upstream*, their effects ripple through exactly the systems a comprehensive blood panel measures, and many of those effects are silent until they're advanced: - **Growth-hormone-releasing peptides** (CJC-1295, ipamorelin, sermorelin, MK-677/ibutamoren) raise IGF-1 and can nudge fasting glucose and insulin. You won't feel a rising IGF-1 or a creeping insulin resistance — but both show up in blood. - **GLP-1 receptor agonists** (semaglutide, tirzepatide) can transiently raise liver enzymes, rarely stress the kidneys during dehydration, and — because they work by suppressing appetite — quietly drain the nutrients you're no longer eating enough of. - **Repair and recovery peptides** (BPC-157, TB-500/thymosin) are taken precisely when people don't want to interrupt training or healing — the moment you'd most want objective evidence that organ and inflammation markers are holding steady. The through-line: peptide effects are measurable long before they're noticeable. Bloodwork converts "I think it's working / I feel fine" into a trend line you can actually act on. ## The Three-Draw Rhythm: Baseline, Early Follow-Up, Quarterly Clinicians who monitor peptide therapy well tend to follow the same cadence, and it's simple enough to run yourself: - **Baseline (before you start).** The single most valuable draw. Without a "before" picture, a later result has nothing to be compared against — a normal-looking IGF-1 means little if you don't know where you started. Baseline also catches pre-existing issues that a peptide could worsen. - **Early follow-up (4-6 weeks in).** Confirms the protocol is doing what it should (IGF-1 moving on a GH peptide; glucose and lipids improving on a GLP-1) and that nothing is drifting the wrong way (liver enzymes, insulin) while it's still easy to adjust. - **Quarterly thereafter.** Ongoing therapy calls for ongoing monitoring. Every ~90 days keeps the trend current and catches slow shifts. This is also why a recurring lab plan fits peptide users so naturally — the retest is the whole point. Timing detail that matters: on injectable peptides, draw at **trough** — right before your next dose — for a consistent, comparable baseline. For weekly GLP-1 injections, draw at the same point in your weekly cycle each time. Most of these panels also require a 10-12 hour fast and a morning draw for accurate cortisol and hormone readings. ## What to Monitor, by Peptide Type Different peptides stress different systems. The markers that matter most: **GH-releasing peptides (CJC-1295, ipamorelin, sermorelin, MK-677).** [IGF-1](https://www.test-well.com/tests/igf-1) is the primary efficacy marker — it's the stable downstream signal of growth-hormone activity, and if it isn't moving, the protocol isn't doing much. Pair it with fasting glucose, [insulin](https://www.test-well.com/tests/insulin-fasting), and [HbA1c](https://www.test-well.com/tests/hemoglobin-a1c), because GH-axis stimulation can raise blood sugar, plus a full [thyroid](https://www.test-well.com/tests/tsh) panel and IGF-1's metabolic neighbors. **GLP-1 medications (semaglutide, tirzepatide).** Liver and kidney function via [CMP](https://www.test-well.com/tests/comprehensive-metabolic-panel), glucose control via A1c and insulin, lipids, thyroid, and the nutrition markers that fall on an appetite-suppressed diet — [B12](https://www.test-well.com/tests/vitamin-b12), [ferritin](https://www.test-well.com/tests/ferritin), [vitamin D](https://www.test-well.com/tests/vitamin-d). Our [GLP-1 lab monitoring guide](https://www.test-well.com/guides/glp1-lab-monitoring) covers this in depth. **Repair peptides (BPC-157, TB-500).** There's no single "BPC-157 marker," so monitoring is about safety and baseline stability: organ function (CMP), blood health ([CBC](https://www.test-well.com/tests/cbc-with-differential)), and inflammation ([hs-CRP](https://www.test-well.com/tests/hs-crp)). Our [BPC-157 bloodwork guide](https://www.test-well.com/guides/bpc-157-safety-bloodwork) explains what you can and can't learn from labs here. Rather than assemble these piecemeal, the [Peptide Therapy Monitoring Panel](https://www.test-well.com/tests/standardized-peptide-panel) bundles all 53 biomarkers most peptide users track — including SHBG for accurate free-testosterone interpretation — into one draw at roughly half the à la carte cost. ## A Note on Safety, Legality, and What This Testing Is (and Isn't) Being straight about this builds more trust than glossing over it: Many research peptides (BPC-157, TB-500, and most GH secretagogues) are **not FDA-approved for general human use** and are sold "for research purposes only." GLP-1 medications like semaglutide and tirzepatide are FDA-approved but are prescription drugs meant to be taken under medical supervision. TestWell does not sell, source, prescribe, or dose peptides, and nothing here is a recommendation to start any peptide. What bloodwork offers is **harm reduction and measurement**: if you or your clinician have decided on a protocol, objective labs before and during are how you catch problems early and confirm benefit. That's a genuinely valuable, defensible use of testing — the same principle behind monitoring any therapy by its effects on the body. Every TestWell order is reviewed by a licensed physician, drawn at CLIA-certified labs, and returned with a plain-language summary in your portal. If a result is abnormal, that's your cue to involve a clinician — bloodwork informs the conversation, it doesn't replace it. ## Frequently asked questions ### Can a blood test tell me if my peptides are real or high quality? No. A blood test measures how your body responds to a peptide — your IGF-1, hormones, metabolic and organ markers. It cannot verify the identity, purity, or concentration of what's in the vial; that's a chemical assay from a substance-testing lab, not a medical lab. What bloodwork can tell you indirectly: if a GH-releasing peptide isn't moving your IGF-1 at all, either the protocol or the product isn't doing what's expected. ### What labs should I get before starting peptides? A baseline draw before you start is the most valuable test you'll run. For GH-releasing peptides that means IGF-1, glucose, insulin, A1c, a full thyroid panel, and hormones. For GLP-1s it means a CMP (liver + kidney), A1c, insulin, lipids, thyroid, and nutrition markers. The Peptide Therapy Monitoring Panel covers the full baseline in one draw; the GLP-1 Monitoring panel is the purpose-built option for semaglutide or tirzepatide. ### How often should I get bloodwork on peptide therapy? The common cadence is baseline (before starting), a follow-up at 4-6 weeks to confirm response and safety, then quarterly for as long as you're on the protocol. Peptide therapy is ongoing, so monitoring is ongoing — which is why many users set up a recurring quarterly lab plan rather than remembering to reorder each time. ### When should I draw blood relative to my peptide dose? For injectable peptides, draw at trough — right before your next scheduled dose — so every draw is comparable. For weekly GLP-1 injections, draw at the same point in your weekly cycle each time (often 3-4 days post-injection). Most peptide panels also require a 10-12 hour fast and a morning draw for accurate cortisol and hormone levels. ### Is IGF-1 the marker for all peptides? IGF-1 is the primary marker for growth-hormone-releasing peptides (CJC-1295, ipamorelin, sermorelin, MK-677) because it's the stable downstream signal of GH activity. It's not relevant to GLP-1s (tracked by glucose, A1c, and organ markers) or to repair peptides like BPC-157 (monitored by organ and inflammation markers). Matching the marker to the peptide is the whole point of choosing the right panel. ### Does TestWell sell or prescribe peptides? No. TestWell provides physician-reviewed bloodwork only — the labs that let you and your clinician monitor a peptide protocol's safety and effectiveness. We don't sell, source, prescribe, or advise on dosing peptides. Many research peptides aren't FDA-approved for general use, and GLP-1 medications are prescriptions; testing is about measuring your body's response, not endorsing any protocol. ### Are peptides safe? It depends entirely on the peptide, the person, and the protocol — and it's not something a website can answer for you. Prescription GLP-1s have well-studied safety profiles under medical supervision; many research peptides lack large human safety trials and are not FDA-approved for general use. What you can do regardless is monitor your own physiology: baseline and periodic bloodwork catches the organ, metabolic, and hormonal effects that would otherwise stay silent, which is the practical core of using any peptide more safely. ## Sources - [FDA — Human Drug Compounding (bulk drug substances and the 503A framework)](https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding) - [MedlinePlus (NIH) — Comprehensive Metabolic Panel (CMP)](https://medlineplus.gov/lab-tests/comprehensive-metabolic-panel-cmp/) - [American Diabetes Association — Standards of Care in Diabetes 2024, §9 Pharmacologic Approaches](https://doi.org/10.2337/dc24-S009) --- Canonical page: https://www.test-well.com/guides/peptide-therapy-bloodwork Machine-readable catalog: https://www.test-well.com/api/catalog.json · MCP server: https://www.test-well.com/mcp · Overview for agents: https://www.test-well.com/llms.txt Prices are cash-pay, in USD, and include physician authorization; every order adds one flat $6 lab processing fee. Educational content is not a diagnosis — discuss results with a clinician.